BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-5 out of 5 found
  Current Search:  xalatan: 5     

HTML
100%
Pfizer Q4 profit, FY10 outlook fall short of estimates
2/3/2010 9:33 AM ET RELATED NEWS Trade PFE now with TOP MARKET NEWS (RTTNews) - Pharmaceutical giant Pfizer Inc.

(PFE: News ) on Wednesday reported a profit for the fourth quarter that almost tripled from last year, when results were negatively impacted by a...

RTTNews.com:  Feb 3 2010 3:24PM
Matching: xalatan
Find similar documents
HTML
100%
Pfizer Q4 Profit, FY10 Outlook Falls Short Of Estimates - Update
(RTTNews) - Pharmaceutical giant Pfizer Inc.

(PFE) on Wednesday reported a profit for the third quarter that almost tripled from last year, when results were negatively impacted by a hefty charge.

Revenues for the quarter surged 34% from last year.

Canada News Wire via Quote.com:  Feb 3 2010 2:48PM
Matching: xalatan
Find similar documents
HTML
100%
Pfizer CEO Jeffrey Kindler Honored With Catalyst Award At Glaucoma Research Foundation Benefit
Jeffrey B.

Kindler received the 2010 Catalyst Award, the Glaucoma Research Foundation's highest honor, acknowledging his exemplary leadership in sustaining innovative research and education.

Kindler is Chief Executive Officer and Chairman of the Board of...

Medical News Today:  Feb 1 2010 1:17PM
Matching: xalatan
Find similar documents
HTML
100%
Study: Prostaglandin analogue has good safety profile in treating pediatric glaucoma
Latanoprost is a safe treatment for pediatric glaucoma, lowering IOP in 35% of cases with interpretable IOP data, a large retrospective study found.

'This large study of latanoprost-treated children confirms the excellent safety profile of the drug in the...

PCON SuperSite:  Jan 7 2010 10:44AM
Matching: xalatan
Find similar documents
HTML
100%
Study: Prostaglandin analogue has good safety profile in treating pediatric glaucoma
Latanoprost is a safe treatment for pediatric glaucoma, lowering IOP in 35% of cases with interpretable IOP data, a large retrospective study found.

'This large study of latanoprost-treated children confirms the excellent safety profile of the drug in the...

OSN Super Site:  Jan 6 2010 5:01PM
Matching: xalatan
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.